OncoLink Cancer Treatment and Resources

Use of robots to improve patients' treatment and throughput



Reporter: Arpi Thukral, MD MPH
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: May 12, 2011

Presenter: Regis Ferrand
Presenter's Affiliation: Institut Curie-Centre de Protontherapie d'Orsay

Presentation/Overview

  • The purpose of this presentation was to provide an overview of the 15-20 year history of the use of robotic couches at Institut Curie-Centre de Protontherapie d'Orsay (CPO).
  • In the past 15 years, use of robotic positioning has developed tremendously in radiation therapy, particularly in particle therapy.
  • The challenge of robotic positioning is that it must be fast and precise.
    • Precise:
      • Need 6 degrees of freedom, long range motion <0.5 mm, with smooth trajectories
      • Need high repeatibility for QA checks and calibration
      • Short range of motion: 0.2 mm
    • Fast:
      • Ability to load/unload patient
      • Need to use a combination of fields
      • Fast detection of unexpected motion
      • Collision avoidance/back to safe position
  • History of robots
      • Before 1990: prototypes: MGH/HCL chair or eye chairs (CPO, PSI, MGH, Nice)
      • 1995-2003 – 6 axis robot based (ex. MPRI)
      • 2003-2009 – Scara-based, hexapode based
      • 2010 – new hybrid designs (Poros PPS, Toshiba PPS)
  • Extended use of robots besides patient postioning:
    • Robotic CBCT
    • MPRI snouth changer
    • Trolleys (PSI, automated in Essen)
    • Use of robots to calibrate devices inside the treatment room
    • Chair and couch
  • The CPO modest experience of 20 years:
    • The CPO has been working on 4 different robots since 1990. These include:
      • Hexapodes (original in 1991 and new version in 2006)
        • accuracy <0.2 mm with limited range through +/- 10 degrees
        • 2006 version has 360 degree vertical rotation
        • not ideal for long range motion
      • 6 axis based (1995)
        • accuracy approx 3 mm
        • The biggest advantage of this type is repeatibility.
      • Scara based (Forte/Procure)
        • Approx 0.5 mm precision
      • New pit free prototype
        • Developed within the frame of a research project.
        • Specific architecture
        • Intrinisic high precision (+/- 0.5 mm accuracy over long range movements)
        • Ability to align patient inside and outside room
        • Water tank permanently ready to use
  • Lessons learned from 20 year experience at CPO:
    • Except for hexapode, the intrinsic precision is NOT sufficient
      • Calibration is mandatory and takes time.
    • Robot has high potential and is designed for guidance.
      • Has incredible robustness (only 3 problems in 15 years at CPO, likely due to neutrons)
  • Future directions/concepts:
    • New robotic concepts: (ex. Poros prototype, patented):
      • Increased working envelope
      • Intrinsic precision enhanced
      • Reduced cycle (20 ms) – dynamic motion
      • Hardware redundant saftely systems
    • Fluid process
      • Natural ability for: alignment inside/outside and adaptive therapy
      • Simultaneous multi-PAS guidance
      • Definition of true postioning strategy at the OIS level.

Author's Conclusions

  • To compare proton and proton treatment, we need to dramatically improve the treatment process for protons (and not only the beam).
  • Robotic patient positioners have proven their potential to play a key role in this process.
  • However, there are still many advances that need to be made in this field for proton therapy.

Clinical Implications

  • The author of this presentation clearly highlighted the history and advances made in the last 2 decades regarding the use of robotic technology to improve patient treatment and throughput in the proton arena.
  • Robots play a key role in patient positioning, which in turn translates to greater efficiency in patient throughput.
  • From this overview, we are able to assess the value and limitations of robotic patient positioning. This will help guide the development of future robotic technology for particle therapy.
  • Future studies may focus not only on improving this technology, but also advancing it in terms of image guidance, safety and dynamic motion.
  • Furthermore, efforts to adapt a global positioning process to specific clinical protocols are underway.

OncoLink I wish u knew...

Ms. Wagner discusses diet during cancer treatment and balancing nutritional needs and side effects. Read more.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS